Six high-risk patients being kept in isolation at Carlos III Hospital
The two doctors who treated Ebola patient Teresa Romero in Alcorcón are latest arrivals


Six people were being kept in isolation at Carlos III Hospital in Madrid on Wednesday night as health authorities sought to contain the spread of the Ebola virus that has infected nursing assistant Teresa Romero, the first person to contract the disease outside of Africa.
The latest patients to be admitted were the two doctors who treated Romero in Alcorcón before she was transferred to an isolation unit at Carlos III. They arrived at the center on Wednesday night as a preventive measure, healthcare sources reported.
One of them is Juan Manuel Parra, a doctor attached to Alcorcón Hospital’s emergency unit, who has already filed a report to his superiors explaining how he spent 16 hours treating Romero without adequate protection.
The other medic is the primary care doctor whom Romero visited on September 30.
In addition, another nurse from the team who treated the two Ebola-infected missionaries repatriated from Liberia and Sierra Leone, Miguel Pajares and Manuel García Viejo, was also admitted to Carlos III on Wednesday to be tested for the virus.
Two people under observation have now been discharged from the hospital after testing negative for Ebola in their second test on Wednesday. They are a nurse from the medical team who treated the missionaries and a Spanish engineer recently returned from Nigeria.
Neither of the two doctors most recently admitted have shown any signs that they might be infected but have been isolated in the observation floor containing those who had close contact with the virus as a preventive measure. It is the same floor where Romero’s husband, who has also shown no symptoms, is also staying.
The other people there are Romero herself and another nurse who treated García Viejo, who is waiting to be tested for the virus.
Tu suscripción se está usando en otro dispositivo
¿Quieres añadir otro usuario a tu suscripción?
Si continúas leyendo en este dispositivo, no se podrá leer en el otro.
FlechaTu suscripción se está usando en otro dispositivo y solo puedes acceder a EL PAÍS desde un dispositivo a la vez.
Si quieres compartir tu cuenta, cambia tu suscripción a la modalidad Premium, así podrás añadir otro usuario. Cada uno accederá con su propia cuenta de email, lo que os permitirá personalizar vuestra experiencia en EL PAÍS.
¿Tienes una suscripción de empresa? Accede aquí para contratar más cuentas.
En el caso de no saber quién está usando tu cuenta, te recomendamos cambiar tu contraseña aquí.
Si decides continuar compartiendo tu cuenta, este mensaje se mostrará en tu dispositivo y en el de la otra persona que está usando tu cuenta de forma indefinida, afectando a tu experiencia de lectura. Puedes consultar aquí los términos y condiciones de la suscripción digital.
More information
Últimas noticias
Magnets in their heads: How some animals guide themselves using the Earth’s magnetic field
From Hungary’s Orbán to Chile’s Kast: How Trump helps turbo charge the far right
From Andorra to Gibraltar, a black market for Ozempic exploits its success: ‘They’re the most sought-after products in the world’
From safe-haven investment to geostrategic weapon: Who owns the most gold and where are the bars kept?
Most viewed
- Why we lost the habit of sleeping in two segments and how that changed our sense of time
- Trump’s obsession with putting his name on everything is unprecedented in the United States
- Charles Dubouloz, mountaineering star, retires at 36 with a farewell tour inspired by Walter Bonatti
- Venezuela faces its most tense Christmas yet
- CBS in crisis after pulling a report on Trump’s deportations to El Salvador (which later leaked online)









































